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eEF2K (eukaryotic elongation factor 2 kinase) is a Ca
2+/CaM
(calmodulin)-dependent protein kinase which regulates the
translation elongation machinery. eEF2K belongs to the small
group of so-called ‘α-kinases’ which are distinct from the main
eukaryotic protein kinase superfamily. In addition to the
α-kinase catalytic domain, other domains have been identiﬁed
in eEF2K: a CaM-binding region, N-terminal to the kinase
domain; a C-terminal region containing several predicted
α-helices (resembling SEL1 domains); and a probably rather
unstructured ‘linker’ region connecting them. In the present
paper, we demonstrate: (i) that several highly conserved residues,
implicated in binding ATP or metal ions, are critical for eEF2K
activity; (ii) that Ca
2+/CaM enhance the ability of eEF2K to
bind to ATP, providing the ﬁrst insight into the allosteric control
of eEF2K; (iii) that the CaM-binding/α-kinase domain of eEF2K
itselfpossessesautokinaseactivity,butisunabletophosphorylate
substrates in trans; (iv) that phosphorylation of these substrates
requires the SEL1-like domains of eEF2K; and (v) that highly
conserved residues in the C-terminal tip of eEF2K are essential
for the phosphorylation of eEF2, but not a peptide substrate. On
the basis of these ﬁndings, we propose a model for the functional
organization and control of eEF2K.
Key words: calmodulin (CaM), eukaryotic elongation factor 2
(eEF2) , α-kinase, SEL1 domain.
INTRODUCTION
eEF2K [eEF2 (eukaryotic elongation factor 2) kinase] catalyses
thephosphorylationofeEF2,whichinactivateseEF2byimpairing
its ability to bind to the ribosome [1,2]. eEF2K was ﬁrst identiﬁed
as a Ca
2+/CaM (calmodulin)-dependent enzyme [3]. Following
the cloning of cDNAs encoding eEF2K, it became clear that
eEF2K does not belong to the main eukaryotic superfamily of
protein kinases, but instead to a small group of genes dubbed
‘α-kinases’ [4,5]. The α-kinases display no clear sequence homo-
logy to other protein kinases [6]. eEF2K is a well-characterized
member of this group; its substrate eEF2 is known and there
is substantial information on the intracellular regulation of
eEF2K activity (reviewed in [7,8]). In contrast, less information
is available about these aspects for other members of this group,
although MHCKA (myosin heavy-chain kinase A), in particular,
has been studied in considerable detail (see for example [9–
11]). The ﬁrst crystal structure for an α-kinase (for the kinase
domain of the ion-channel TRPM7 (transient receptor potential
melastatin-like 7, also termed ChaK1 (channel-kinase 1) [12])
revealed that, despite the lack of sequence homology, the three-
dimensionalstructureofthisα-kinasedisplayedmarkedsimilarity
to members of the main eukaryotic protein kinase superfamily.
Structureshavealsonowbeendeterminedforthecatalyticdomain
of Dictyostelium MHCKA [13], and these show substantial
similaritytothatoftheα-kinasedomainofTRPM7.BothTRPM7
andthecloselyrelatedchannelTRPM6havebeenstudiedinsome
detail (reviewed in [14]); however, the biological signiﬁcance
of their α-kinase domains remains to be elucidated since, for
example, this domain of TRPM7 does not appear to be required
for its channel function [15].
The activity of eEF2K is normally completely dependent upon
Ca
2+/CaM [3,16]. It can also be activated by phosphorylation
by the AMP-activated protein kinase (at Ser
398; [17]) or cAMP-
dependent protein kinase (at Ser
499; [18]). Conversely, its activity
is impaired by signalling through mTORC1 (mammalian target
of rapamycin, complex 1) [19], an effect which involves
phosphorylation of eEF2K at one or more of three sites, Ser
78
[20], Ser
366 [21] and Ser
359 [22].
The overall layout of the structure of eEF2K is depicted in
Figure 1(A). Its α-kinase catalytic domain lies towards the N-
terminus, with the CaM-binding site immediately N-terminal to
this [23,24]. The function of the region that is N-terminal of
the CaM-binding site is not understood. Towards the C-terminus
lie four predicted α-helical regions, which resemble SEL1-type
repeatsfoundincertainotherproteins.Suchfeaturesoftenprovide
a platform for protein–protein interactions [25]. Their role in
eEF2K is unknown. At the extreme C-terminus is a region that
is required for eEF2K to phosphorylate its substrate, eEF2 [24].
Between the catalytic and SEL1-type domains lies a region that is
predictedtobeunstructuredandwhichmayactasalinkerbetween
the two other major domains. Indeed, the fact that this region is
highly conserved (Figure 1A) suggests that it is important for the
function and/or regulation of eEF2K.
The functional organization and regulation of eEF2K remain
poorly characterized, although eEF2K is the best-understood
memberofthisgroupintermsofbothitsphysiologicalroleandthe
inputs that modulate its activity. This prompted us to investigate
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Figure 1 Structural organization and sequence conservation of eEF2 kinase
(A) Sequence conservation between vertebrate eEF2K orthologues: grey, residues that are conserved from mammals to ﬁsh/reptiles; green, conserved across the ﬁve of the six species listed, or a
conservative replacement in the sixth species; and blue, conserved in mammals. The sequences and GenBank® accession numbers on which the analysis is based are human (NP-037434), mouse
(AAH55361), cow (NP_001179471), Anolis carolinensis (XP_003229274; the Carolina anole, a reptile), zebra ﬁnch (XP_002197529) and zebra ﬁsh (NP_001002740). (B) Upper panel: structural
layout of full-length eEF2K. Lower panel: the main truncation mutants tested in the present study (data in Figure 4A). This panel is drawn approximately to scale.
the roles of the identiﬁed domains in eEF2K in its function and
its control, in particular the possible interplay between the kinase
domain and C-terminal regions of eEF2K.
The results of the present study show that the extreme N-
terminal, linker and C-terminal ‘SEL1’ regions of eEF2K are not
required for intrinsic activity or control by Ca
2+/CaM. However,
the C-terminal SEL1 region is indispensable for phosphorylation
of substrates in trans, i.e. both the physiological substrate eEF2
and an artiﬁcial peptide substrate. Phosphorylation of eEF2 was
much more strongly dependent upon the highly conserved C-
terminal tip of the eEF2K polypeptide than phosphorylation of
a peptide substrate. The present study shows that the catalytic
and C-terminal domains, expressed separately, can interact with
one another, leading to a model where the C-terminal part of
eEF2K serves to recruit substrates to the catalytic domain for
phosphorylation.
EXPERIMENTAL
Chemicals and other reagents
All chemicals and biochemicals were purchased from
BDH-Merck and Sigma–Aldrich unless otherwise stated.
Chromatography columns were purchased from GE Healthcare.
[α-
32P]ATP and [γ-
32P]ATP were from PerkinElmer. Antisera
against eEF2K and eEF2 (total and phospho-speciﬁc) were as
described previously [17,20] unless stated otherwise. Plasmids
for expression of eEF2K were as described previously [20,26]
and were sequenced prior to use. eEF2 was puriﬁed from
HeLa cell lysates (CilBiotech) as described by Knebel et al.
[27].
Cloning and mutagenesis
For expression in Escherichia coli, the cDNA for human
eEF2K was cloned between the BamHI and XhoI sites of the
vector pGEX-6P (GE Healthcare), which yields a fusion protein
containing GST (glutathione transferase) at the N-terminus. This
can be removed by cleavage by the PreScission
TM protease.
Mutations were introduced by PCR mutagenesis using the
QuikChange
TM system (Stratagene). C-terminal truncations were
created by introducing a termination codon at the appropriate
position in the sequence, again using QuikChange
TM.F r a g m e n t s
of human eEF2K were created by amplifying the appropriate
portion of the cDNA sequence (by PCR) and cloning this into the
pGEX-6P vector. All vectors were resequenced prior to use.
For some experiments, eEF2K or mutants were expressed in
HEK(humanembryonickidney)-293cells.ThecDNAforeEF2K
wasinsertedintothevectorpHM[28],whichprovidesN-terminal
His6 andMyctags.MutationswereintroducedbyQuikChange
TM,
and the vectors were resequenced.
To allow co-expression of two human eEF2K domain frag-
ments, a different vector system was used. An N-terminal eEF2K
fragment, eEF2K[48–336] was cloned into the T7 expression
vector pNICZb, which provides N-terminal His6 and Z-basic
[29] tags. A C-terminal eEF2K fragment, eEF2K[490–725], was
cloned into the Duet expression vector pCDF, which provides an
N-terminal His6 tag. The tags were removed by cleavage using
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the TEV (tobacco etch virus) protease (Invitrogen). Vectors were
created using a ligation-independent cloning method [30,31].
Protein expression
For expression of GST-tagged eEF2K in bacteria, chemically
competent E. coli Rosetta cells (Novagen) were transformed with
the appropriate vector and grown at 37◦C in LB (Luria–Bertani)
medium supplemented with 100 μg/ml ampicillin and 34 μg/ml
chloramphenicol. When the attenuance at 600 nm had reached
0.5, expression of GST–eEF2K was induced by adding 0.5 mM
isopropyl β-D-thiogalactoside. Cells were grown for a further
16 h at 18◦C prior to harvesting. Although induction at 25◦C
gave a higher total yield of GST–eEF2K, much less of the
protein was soluble. Cells were broken by sonication in buffer
comprising 50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 0.5 mM
EDTA, 0.5 mM EGTA, 5% (v/v) glycerol, 0.03% Brij 35,
14 mM 2-mercaptoethanol, PMSF (added just prior to use),
1 mM benzamidine, and 1 mM each of leupeptin, pepstatin and
antipain. GST–eEF2K was puriﬁed on glutathione–Sepharose,
being eluted with buffer containing 10 mM reduced glutathione.
The pair of recombinant constructs, pNICZb containing
eEF2K[48–336] and pCDF containing eEF2K[490–725], were
co-transformed into competent E. coli Rosetta cells and plated
on to LB agar plates supplemented with 50 μg/ml kanamycin
and 50 μg/ml spectinomycin. (It was necessary to express these
two fragments together in order to obtain sufﬁcient quantities of
soluble protein). Transformants were grown in LB medium in
the presence of both kanamycin and spectinomycin (to maintain
selection for cells harbouring both plasmids) to a D600 of 0.6 at
37◦C.
Protein expression was induced by the addition of isopropyl
β-D-thiogalactopyranosidetoaﬁnalconcentrationof1 mM.Cells
were grown for a further 16 h at 18◦C prior to harvesting.
Cells were resuspended in buffer A (50 mM Hepes, pH 7.5,
300 mM NaCl, 5% (v/v) glycerol, 1 mM 2-mercaptoethanol,
PMSF added just prior to use and 10 mM imidazole) and
then sonicated and clariﬁed by centrifugation (16000 g for
15 min at 4◦C). The lysate was loaded on to Ni-NTA (Ni
2+-
nitrilotriacetic acid) agarose resin (Qiagen). The column was
washed with buffer A and eluted with buffer A containing
250 mM imidazole. The eluted protein was then applied to a
HiTrap SP column equilibrated in 50 mM Hepes, pH 7.5, 50 mM
NaCl and 5 mM 2-mercaptoethanol. The column was washed
extensively with 50 mM Hepes, pH 7.5, 200 mM NaCl and 5 mM
2-mercaptoethanol,andtheproteinwaselutedwith50 mMHepes,
pH 7.5, 700 mM NaCl and 5 mM 2-mercaptoethanol. The frac-
tionscontainingtheeEF2Kcomplexwerepooled.Theproteinwas
treatedwithTEVproteaseat4◦Covernightandconcentrated.The
concentrated protein was applied to a HiLoad Superdex 75 16/60
gel ﬁltration column (Pharmacia) pre-equilibrated in 50 mM
Hepes, pH 7.5, 150 mM KCl and 2 mM 2-mercaptoethanol. The
purity of all recombinant proteins was conﬁrmed by SDS/PAGE
followed by staining with Coomassie Brilliant Blue.
For expression of eEF2K in mammalian cells, the appropriate
pHM-eEF2K vectors were transfected into HEK-293 cells as
described previously [32]. The cells were lysed 48 h later and
eEF2K proteins were isolated by virtue of their His6 tag using
Ni-NTA agarose according to the manufacturer’s instructions.
Assays for eEF2 kinase activity
Assays of eEF2K activity were performed using buffer B
[ﬁnal concentrations: 50 mM Mops, pH 7.0 (unless pH stated
otherwise), 20 μg/ml CaM (unless omitted), 5 mM MgCl2,
14 mM 2-mercaptoethanol, 0.67 mM CaCl2,2 m ME D T A ,
0.4 mM EGTA, 1 mM benzamidine, and 1 mM each of leupeptin,
pepstatin and antipain]. Reactions, in a total volume of typically
20 μl, contained 1 μg of puriﬁed eEF2 and were initiated
by adding [γ-
32P]ATP (ﬁnal concentration 0.1 mM, 1 μCi per
reaction). Reactions were incubated at 30◦C for the appropriate
time (up to 30 min) and then SDS/PAGE sample buffer was
added. The samples were immediately heated at 95◦Cf o r5m i n
to denature the proteins and stop the reaction. Products were
analysed by SDS/PAGE (10% gel) and, after staining with
Coomassie Brilliant Blue, the gels were placed into destain/ﬁxing
solution [50% (v/v) methanol and 10% (v/v) acetic acid]. Gels
were then placed on Whatman 3MM paper, covered with Saran
wrap and then dried on a vacuum gel dryer. Radioactivity was
detected either by autoradiography or using a phosphorimager
(Typhoon, GE Healthcare).
Assays of eEF2K activity against the MH-1 peptide were
performed in buffer B essentially as described above, except that
analysis involved spotting samples from the reaction mixture
on to phosphocellulose paper (P81, Whatman). Filters were
immediately placed in approximately 300 ml (for up to 25 ﬁlters)
of 75 mM orthophosphoric acid and washed three further times in
asimilar volumeof75 mMorthophosphoricacid.Theywerethen
rinsedinethanolanddriedinanovenat100◦C.Radioactivitywas
determined using ˇ Cerenkov counting.
UV cross-linking
The interaction between eEF2K and ATP was studied by UV
cross-linking, using recombinant GST–eEF2K, in the presence
or absence of CaM and CaCl2 in buffer B, but using [α-
32P]ATP
instead of [γ-
32P]ATP. UV irradiation was performed using a
hand-heldlightsource(UVPModelUVGL-58,Mineralightlamp,
emissionwavelengthmaximumat254 nm)held2–3 cmabovethe
open microfuge tube containing the sample for 60 min. Samples
were then subjected to SDS/PAGE and autoradiography.
SDS/PAGE and immunoblotting
SDS/PAGE was performed using the BioRad Laboratories
Protean 3 mini-slab gel system, using the procedure ﬁrst
described by Laemmli [33]. Immunoblotting was performed
by electrotransferring proteins resolved by SDS/PAGE on to
nitrocellulose membranes. Membranes were then blocked in PBS
with 0.05% Tween 20 containing 5% (w/v) skimmed milk
powder for 1 h at room temperature (20–22◦C). Membranes were
probed with the indicated primary antibody overnight at 4◦C.
After incubation with ﬂuorescently tagged secondary antibody,
signals were detected using a Li-Cor Odyssey® imaging system.
ELISA assays
To study the association of CaM with a biotinylated peptide
corresponding to the CaM-binding region of human eEF2K
(residues 76–95), or a variant which contains phosphoserine, not
serine, at position 78, the wells of a Maxisorp ELISA tray (Nunc)
were coated overnight at 4◦C with CaM (0.2 μg/ml) in PBS.
Wells were then washed with PBS containing 0.05% Tween
20, and blocked with 5% (w/v) BSA in the same buffer.
The eEF2K[76–95] peptide was appropriately diluted in 50 mM
Mops (at pH 6.5 or 7.5), 100 mM NaCl, 2 mM CaCl2,0 . 0 5 %
Tween 20 and 0.5% BSA. The various dilutions of the peptide
were added to wells in triplicate in 100 μl. After 1 h at room
temperature, the wells were washed with buffer comprising
50 mM Mops, 100 mM NaCl and 0.05% Tween 20 at pH 6.5 or
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7.5, and either 2 mM CaCl2 or 1 mM EGTA. Streptavidin–HRP
(horseradish peroxidase; Pierce; 0.1 μg/ml) in the corresponding
buffer was then added and plates were incubated for 30 min at
room temperature, before being washed again. HRP activity was
assessed using 3,3
 ,5,5
 -tetramethylbenzamidine and absorbance
was read at 450 nm.
To study the interaction of eEF2K with CaM by ELISA, a
similar method was used, except that, after coating the plates
with CaM, wells were probed with GST, GST–eEF2K or GST–
eEF2K[W85G], and detection was performed using an anti-
GST antibody followed by an anti-IgG–HRP antibody. When
ELISA was used to study the association between the N- and C-
terminaldomainsofeEF2K,thewellswereﬁrstcoatedwithGST–
eEF2K[1–402] and then probed with GST–eEF2K[478–725] or,
as a negative control, GST.
Analytical gel ﬁltration
Analytical gel-ﬁltration chromatography experiments were
carried out using a Superdex 75 10/300 gel ﬁltration column
on an ¨ AKTA puriﬁer (GE Healthcare). The column was pre-
equilibrated in 50 mM Hepes, pH 7.5, 150 mM NaCl and 5 mM
2-mercaptoethanol in the absence or presence of 6 mM CaCl2.
Puriﬁed eEF2K[48–336] or eEF2K[490–725] (0.6 mg/ml) in the
absence or presence of CaM (1:1 ratio) was loaded on to a 100 μl
sample loop and then injected into the gel ﬁltration column at
a ﬂow rate of 0.5 ml/min. Fractions of 200 μl were collected
and analysed by SDS/PAGE. CaM (0.4 mg/ml) on its own was
analysed as a control. The column had previously been calibrated
with proteins of known molecular mass. The elution proﬁles at
280 nm were recorded.
Analysis of binding to SP Sepharose
To study the interaction of the catalytic and SEL1 domain
of eEF2K, we performed SP Sepharose-binding experiments
utilizing the presence of two different tags. The His6–Zb-
eEF2K[48–336] and His6–eEF2K[490-725] fragments in 50 mM
Hepes(pH 7.5)and75 mMNaClwereappliedtopre-equilibrated
SP Sepharose resin in 50 mM Hepes (pH 7.5) and 75 mM NaCl
containing either 2 mM Ca
2+ or 4 mM EDTA and incubated
for 30 min at 4◦C. The resin was washed three times with the
same buffer containing either 2 mM CaCl2 or 4 mM EDTA. The
protein was then eluted with 50 mM Hepes (pH 7.5) and 1 M
NaCl.Samplesoftheﬂow-through(unboundmaterial)andelution
were analysed by SDS/PAGE. To study the interaction of eEF2K
with CaM the same method was used, except that CaM was
added. It was also veriﬁed that His6–eEF2K[490–725] and CaM
did not bind to the SP Sepharose resin alone (see the Results
section).
Analysis of binding of eEF2K to CaM–Sepharose
To study the interaction of eEF2K with CaM further, we
performed CaM–Sepharose-binding experiments with wild-type
GST–eEF2K. Each sample, in 50 mM Mops (pH 7.5) and
150 mM NaCl, was applied to CaM–Sepharose
TM 4B (GE
Healthcare) pre-equilibrated in 50 mM Mops (pH 6.5 or 7.5)
and 150 mM NaCl; and either 2 mM CaCl2 or 4 mM EDTA and
incubated for 30 min at 4◦C. The resin was washed three times
with the appropriate corresponding buffer. The protein was then
elutedwith50 mMMops,pH 6.5or7.5,150 mMNaCland4 mM
EDTA. Samples of the ﬂow-through and elution were analysed
by SDS/PAGE.
NMR sample preparation
Samples (six 0.5 ml aliquots) were prepared for NMR STD
(saturation transfer difference) experiments. Sample 1: 0.5 mM
ATP-γS (adenosine 5
 -[thio]triphosphate; a non-hydrolysable
ATP analogue) in 99.9% pure
2H2O. Sample 2: eEF2K[48–
336] and eEF2K[490–725] at 9 μMi n2 0m MH e p e s ,p H7 . 5 ,
150 mM KCl, 2 mM 2-mercaptoethanol and 1 mM ATP-γS.
Sample 3: Sample 2 without ATP-γS. Sample 4: 100 μMC a Mi n
20 mM Hepes, pH 7.5, 150 mM KCl, 1 mM CaCl2 and 1 mM
ATP-γS. Sample 5: Sample 4 without ATP-γS. Sample 6:
9 μM eEF2K[48–336] and eEF2K[490–725] and 90 μMC a M
in 20 mM Hepes, pH 7.5, 150 mM KCl, 1 mM CaCl2 and 1 mM
ATP-γS.
Acquisition of NMR spectra
All NMR experiments were recorded at a temperature of 298 K
with a spectral width of 10 kHz on a Varian INOVA-600
instrument with a Z-gradient room temperature triple resonance
probe (Agilent). The
1H NMR chemical shifts were referenced
to the residual HDO signal at 4.78 ppm. A standard Biopack
STDexperimentalprocedurewasused.Selectivesaturationofthe
protein resonances was achieved by a train of Gaussian-shaped
50 ms pulses for 2 s at 1.5 ppm (on-resonance) and 30 ppm
(off-resonance). Residual water suppression was achieved by
excitation sculpting and protein signals were suppressed by a
40 ms trim pulse. The on- and off-resonance spectra were
subtracted during the pulse programme execution via phase
cycling,andtheresultingspectrawereprocessedusingVnmr6.1c.
RESULTS
Conserved residues in the catalytic domain and the proposed
metal ion-binding site are essential for eEF2K function
Many residues within the kinase domain are conserved between
eEF2Ksequencesfromdisparatespecies(Figure1A)andbetween
these enzymes and other members of the α-kinase family [34].
The available crystal structures of the kinase domains of TRPM7
(ChaK1) [12] and the Dictyostelium MHCKA [13] reveal that
some of the highly conserved residues may interact with the
substrate ATP. Based on the three-dimensional structure of
TRPM7[12],Lys
170 ineEF2Kprobablyliesinasimilarpositionto
Lys
72 inPKA(proteinkinaseA).Thisresidueisstrictlyconserved
in members of the main kinase superfamily and interacts with
the α-a n dβ-phosphates of ATP; mutating it strongly impairs
kinase activity. We therefore tested the effect of mutating this
residue in eEF2K to methionine (similar size but uncharged).
The K170M mutant was essentially completely inactive both in
autophosphorylation and in phosphorylating either eEF2 or the
MH-1 peptide (Figures 2A and 2B). Even a more conservative
replacement by arginine resulted in essentially complete loss of
activity (K170R; Figure 2B). Assays conducted for longer time
periods revealed that these Lys
170 mutants do retain <0.5% of
the wild-type activity (results not shown). Asp
274 is universally
conserved in α-kinases and is located close to the phosphates of
thesubstrateATPinthestructureofTRPM7[12].Mutationofthis
residue to alanine caused a complete loss of detectable activity
(Figure 2A).
The structures of both ChaK1 and MHCKA revealed the
presence of a Zn
2+ ion coordinated by two histidine and two
cysteine residues [12,13]. Mutation of any of the corresponding
residuesineEF2Ktoalanine(H260A,H213A,C314AandC318A
mutants) led to complete loss of activity (Figure 2A), conﬁrming
that these residues, and presumably coordination of Zn
2+,a r e
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Figure 2 Analysis of eEF2K mutants
(A)DataforactivityandATPbinding(UVcross-linkingof[α-32P]ATP)towild-typeGST–eEF2K
or the indicated point mutants: data for autophosphorylation of GST–eEF2K or activity against
eEF2 are shown as a comparison (the Figure is an autoradiograph of an SDS/PAGE gel); the
bottom section shows a Coomassie Brilliant Blue-stained gel of the GST–eEF2K proteins used.
(B) Activities of selected point mutants against the MH-1 peptide. All assays were performed
within the linear range of the assay. WT, wild-type.
also critical for the structural integrity and/or activity of eEF2K.
Consistentwiththis,thesemutations,andalsothoseofAsp
274 and
Lys
170, caused a loss of ability to bind ATP, as judged from UV
cross-linking using [α-
32P]ATP (Figure 2A).
Association of eEF2K with CaM
SometargetsforCaMcanbinditevenintheabsenceofCa
2+ ions
[35], e.g. ones containing a so-called ‘IQ’ (Ile-Gln) motif. The
CaM-binding region of eEF2K does contain an Ile-Gln sequence,
but the overall sequence does not conform closely to that of the
standard IQ motif. To test the binding of eEF2K to CaM under
different conditions, we ﬁrst used an ELISA, in which CaM
was immobilized on the plate, and then probed with differing
quantities of GST–eEF2K, or as negative controls, GST itself or
the eEF2K[W85A] mutant (in which a key residue involved in
CaM binding is mutated [24]; Figure 3A). This was performed
in the presence of Ca
2+ ions or of the Ca
2+ chelator EGTA. In the
presence of Ca
2+ ions, a clear interaction was seen with GST–
eEF2K (Figure 3A), but not with GST or GST–eEF2K[W85G].
When EGTA rather than Ca
2+ ions was present, almost no
binding of CaM to GST–eEF2K was seen, except a trace at the
highest concentration of GST–eEF2K used (Figure 3A). These
data indicate that eEF2K only binds weakly, if at all, to CaM in
the absence of Ca
2+ ions.
We also studied the binding of CaM to a peptide based on the
sequencethatincludestheCaM-bindingsitewithineEF2Kwhich
includes Trp
85. At pH 7.5, which is close to physiological pH,
little binding of CaM to this peptide was observed in the presence
of EGTA, but much more association was seen when Ca
2+ was
present, as measured by an ELISA (Figure 3B). Interestingly,
when the pH was lowered to 6.5, binding to CaM increased
substantially in the presence of calcium ions and dramatically
in their absence (Figure 3B). This enhanced binding to CaM
could contribute to the activation of eEF2K that occurs at low pH
[36]. The increased activity of eEF2K at pH values below 7
is not a general feature of α-kinases, as changing the pH did
not affect the activities of MHCKA and TRPM7 in this way
(Pigott, C.R. and Proud, C.G., unpublished work). Indeed, for
MHCKA, a decrease in activity was observed at lower pH
values [37].
We also studied the ability of full-length eEF2K to interact
with CaM, in the absence or presence of Ca
2+ ions, at pH 6.5 or
7.5. GST–eEF2K was applied to CaM–Sepharose beads under
the appropriate conditions. After washing the beads with the
corresponding buffer, bound proteins were eluted with buffer
lacking Ca
2+ ions. The loaded material and the non-bound
and eluted fractions were analysed by SDS/PAGE and Western
blotting (Figure 3C). The data clearly show that eEF2K cannot
stably associate with CaM in the absence of Ca
2+ ions at either
pH in this type of assay.
We also examined the Ca
2+ dependence of the activity of
eEF2K against the MH-1 peptide at both pH values. Activity was
much higher at pH 6.5 than at pH 7.5, in agreement with earlier
data [36], but was still strongly dependent upon the presence of
Ca
2+ ions (Figure 3D), consistent with the requirement for Ca
2+
ions for efﬁcient binding of eEF2K to CaM at both pH values.
The fact that the CaM-binding region of eEF2K contains three
histidine residues which can ionize around neutral pH prompted
us to examine whether they played a role in the effects of pH
on CaM binding, since their positive charge (a feature often
involved in CaM binding) will change over this pH range. We
conducted extensive studies using eEF2K in which one or more
of these residues was replaced by asparagine (uncharged, but
polar side chain) or lysine (charged at pH 7.5 as well as pH 6.5)
and the corresponding peptides failed to reveal any inﬂuence of
the histidine residues on binding to CaM (results not shown). As
shown in Figure 3(E), even when all three histidine residues in
this region were mutated to asparagine, the activity of the enzyme
still responded to decreased pH in a similar way to the wild-type
enzyme. Thus the effect of pH on eEF2K activity does not require
the histidine residues in its CaM-binding region. Other features
of eEF2K must therefore account for this.
The activity of eEF2K is negatively regulated by signalling
through mTORC1 [19], in part through the mTORC1-promoted
phosphorylation of Ser
78, which lies immediately adjacent to the
CaM-binding site. Phosphorylation here negatively inﬂuences
the association of eEF2K with CaM [20]. Consistent with this,
a version of the CaM-binding site peptide in which the equivalent
of Ser
78 has been replaced by a phosphoserine did not bind at all
to CaM at pH 7.5, although some binding was observed at pH 6.5
(Figure 3B). This is consistent with previous data showing that
the phosphorylation of Ser
78 decreased binding of CaM to eEF2K
in human cells [20].
Ca2+/CaM activate eEF2K by regulating eEF2K structure
Although eEF2K was ﬁrst identiﬁed as a Ca
2+/CaM-activated
protein kinase [3], it has not so far been established how
Ca
2+/CaM actually bring about activation of eEF2K (or,
conversely, why eEF2K is inactive in the absence of Ca
2+/CaM).
In other Ca
2+/CaM-dependent kinases, regions outside the
catalytic domain are involved in their control by Ca
2+/CaM
(for example see [38]). To study whether control of eEF2K by
Ca
2+/CaM also requires features outside its catalytic domain, we
created a suite of truncations (Figure 1B).
As shown in Figure 4(A), the fragment 1–402 (containing
the N-terminus, CaM-binding motif, catalytic domain and
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Figure 3 Behaviour of eEF2K with CaM at different pH values
(A)TheassociationofCaMwitheEF2KwastestedbyELISA,usingtheindicatedamountsofwild-type(wt)orW85GmutantGST–eEF2K,asdescribedintheExperimentalsection.GSTwasusedasa
negative control,and binding wasstudied in thepresenceof CaCl2 or EGTAas noted.Results aremeans+ −S.D. Abs, absorbance.(B) Thebindingof biotinylated peptidesbased on theCaM-binding
region of eEF2Kto CaM wasstudied in the absence(EGTA)or presenceof Ca2+ ions at pH6.5 and pH7.5. Thepeptidesused correspondwith the CaM-binding regionof eEF2Kor the samepeptide
with a phosphate on the equivalent of Ser78. Results are means+ −S.D. (C) The binding of wild-type GST–eEF2K to CaM Sepharose in the absence (EDTA) or presence of Ca2+ ions at pH6.5 and
7.5. F/T, ﬂow-through material. (D) Activities of wild-type eEF2K against the MH-1 peptide at pH6.5 or 7.5 in the absence (EGTA) or presence of Ca2+ ions. (E) Activity of wild-type (wt) and the
indicated mutants of GST–eEF2K against the MH-1 peptide over the indicated pH range. All procedures were performed as described in the Experimental section. Results are ??.
∼65 additional residues) undergoes autophosphorylation in a
Ca
2+/CaM-dependent manner. This implies: (i) that the 1–402
fragment does possess catalytic activity and (ii) that it contains
at least one site of autophosphorylation. eEF2K[1–402] also
phosphorylated the eEF2K[478–725] fragment (Figure 4A),
indicating that this C-terminal region contains at least one site
of autophosphorylation.
Of the shorter truncated proteins that we could express well
in E. coli, fragments lacking residues 332 onwards showed very
little activity in autophosphorylation (Figure 4A). Loss of activity
couldreﬂectmisfolding,lackofthedomainsrequiredforfunction
or simply the removal of the autophosphorylated residues. Our
other recent work has indeed identiﬁed residues that are absent
from some of the ‘inactive’ fragments as autophosphorylation
sites (Pyr Dit Ruys, S., Wang, X., Smith, E.W., Herinckx,
G., Hussain, N., Rider, M.H., Vertommen, D. and Proud,
C.P., unpublished results). Interestingly, these fragments (e.g.
eEF2K[1–332],eEF2K[50–332]andeEF2K[64–332];Figure1B)
were also unable to phosphorylate the C-terminal eEF2K[478–
725] fragment, indicating that it is likely that they really are
inactive, and do not simply lack an autophosphorylation site.
In fact, as we have found (Pyr Dit Ruys, S., Wang, X., Smith,
E.W., Herinckx, G., Hussain, N., Rider, M.H., Vertommen,
D. and Proud, C.P., unpublished results), the 333–356 region
does indeed contain two autophosphorylation sites, Thr
348 and
Thr
353, the former playing a key role in the control of eEF2K
activity.
Most of the other longer truncated proteins did show activity
(Figure 4A). All of these fragments contain the previously
identiﬁed CaM-binding site [23,24]. In contrast, a fragment that
contains the region beyond position 332, but lacks the CaM-
binding region (eEF2K[105–402]; Figure 4A), displayed very
low autophosphorylation, much less than the 76–402 fragment
that contains the same C-terminal part. This effect is not due
to removing major autophosphorylation sites since the 76–
104 region contains only one minor site, Ser
78 (Pyr Dit Ruys,
S., Wang, X., Smith, E.W., Herinckx, G., Hussain, N., Rider,
M.H., Vertommen, D. and Proud, C.P., unpublished results). This
concurs with the ﬁndings of Diggle et al. [24] who showed that
removing the ﬁrst 100 residues from eEF2K resulted in loss of
activity. (We cannot, of course, rule out the possibility that some
effects may be due to protein misfolding.)
The autophosphorylation of the 64–356 fragment (and the
slightly longer 64–402 fragment) was strongly stimulated by
Ca
2+/CaM(Figure4B).ThuscontrolbyCa
2+/CaMisanintrinsic
propertyofthecatalyticdomainandadjacentﬂankingregionsand
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Figure 4 Activities of a range of fragments of eEF2K
(A) The indicated fragments, all GST fusions containing the catalytic domain of eEF2K, were incubated with [γ-32P]ATP in the presence of Ca2+/CaM and, where indicated, the eEF2K[478–725]
fragment. The Figure is an autoradiograph of the stained gel. The positions of the catalytic domain fragments (CD) and eEF2K[478–725] are shown. (B)A s( A), using the indicated GST–eEF2K
fragments alone, or in the absence or presence of Ca2+/CaM. The faster-migrating radiolabelled species represent fragments created by proteolytic degradation. (C) GST–eEF2K[64–356] and
eEF2K[478–725] fragments were incubated with the MH-1 peptide in the presence of [γ-32P]ATP with or without Ca2+ ions and CaM for the indicated times.
does not require the extreme N-terminal region, the linker or the
C-terminal SEL1 domains.
Shorter fragments were also capable of autophosphorylation.
The smallest fragment which showed autophosphorylation con-
sisted of residues 76–356, which contains about 30 residues C-
terminal to the conserved α-kinase catalytic domain (Figure 4A,
cf. Figure 1B). Interestingly, fragments lacking residues 1–64
or 1–76 actually tended to show higher activity than the 1–402
polypeptide (Figure 4A), indicating that these N-terminal regions
negatively affect activity. These conclusions are borne out by data
obtained using the MH-1 peptide as substrate (see below).
Regulation of ATP binding by Ca2+/CaM
To study the effects of Ca
2+/CaM on the ability of eEF2K to
interact with its substrate ATP, we used STD NMR. To obtain
sufﬁcient protein for this analysis, we co-expressed the
eEF2K[48–336] and [490–725] fragments. Its association with
ATP was studied in the absence and presence of Ca
2+/CaM. In
this method, NMR signals of ligand protons are detected if the
ligand is bound to the protein. In Figure 5(A), the same section of
the ATP-γS spectrum is shown for four different conditions. The
top spectrum shows the positions of the ATP-γS proton signals,
whereas the absence of any signals in the spectrum below shows
that the STD experiment does not generate a spurious signal that
could be mistaken for bound ligand. The bottom two traces show
proton signals that originate from the ATP-γS bound to eEF2K
in the absence and presence of Ca
2+/CaM, (it was shown in a
separateSTDexperimentthatATP-γSdoesnotbindtoCa
2+/CaM
intheabsenceofeEF2K;resultsnotshown).ThisshowsthatATP-
γS can bind to eEF2K in the absence and presence of Ca
2+/CaM,
suggesting that the ATP-binding site of eEF2K is accessible in
the Ca
2+-free state.
WealsostudiedtheregulationoftheabilityofeEF2Ktointeract
with ATP using UV cross-linking to [α-
32P]ATP. As shown in
Figure 5(B), eEF2K was only cross-linked to labelled ATP when
both CaM and Ca
2+ ions were present. Taken together, these
results suggest that, whereas the ATP-binding site in eEF2K is
accessible in the absence of Ca
2+/CaM, Ca
2+/CaM induces or
stabilizes a conformation in the kinase domain of eEF2K which
positions ATP in the active site in a way that brings it into closer
proximity to residues involved in catalysis. Apparently this effect
does not occur in the presence of CaM alone.
The catalytic and C-terminal domains of eEF2K cooperate in trans
to promote substrate phosphorylation
Althoughthe1–402,76–402and76–356fragmentsallunderwent
autophosphorylation and phosphorylated the eEF2K[478–725]
fragment (Figure 4A), they were completely unable to
phosphorylate eEF2 (Figure 6A). Strikingly, addition of the
eEF2K[478–725] fragment restored activity against eEF2
(Figure 6A). To test whether this property is limited to the
physiological substrate (eEF2) or a more general property of
eEF2K,wealsotestedtheactivitiesofcatalyticdomainfragments
against the MH-1 peptide (Figures 6B–6D). All of the fragments
testedwerealsounabletophosphorylatethissubstrate(Figure6B
and results not shown). Remarkably, addition of the C-terminal
478–725fragmentalsorestoredactivityagainsttheMH-1peptide
(Figure 6B). Thus the N-terminal catalytic domain requires the
C-terminal region containing the SEL1 domains in order to
phosphorylate any known substrate in trans. The SEL1 region
is not needed to impart catalytic activity itself since the catalytic
domain efﬁciently undergoes autophosphorylation in its absence
(Figure 4A). This ﬁnding is consistent with previous studies
[23,24] which suggested that features of the C-terminal part of
eEF2K are needed for phosphorylation of eEF2; importantly, the
results of the present study reveal that the C-terminal fragment
is also required for activity against the only other known eEF2K
substrate, the MH-1 peptide.
Since both fragments are tagged with GST, and GST can form
dimers [39], it was important to establish that the effects observed
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Figure 5 Regulation of the binding of eEF2K to ATP studied by STD NMR
(A)BindingofATP-γStoeEF2KasafunctionofCa2+/CaM.Thesamesectionofthe1Hspectrum
ofa1mMATP-γSsolutionisshownunderfourexperimentalconditions:(i) 1HNMRspectrum
of ATP-γS; (ii) 1H STD spectrum of ATP-γS showing that the STD pulses do not saturate
ATP-γS; (iii) same 1H STD spectrum of ATP-γS in the presence of 9 μM eEF2K[48–336]
and eEF2K[490–725]; and (iv) in the presence of a mixture of 9 μM eEF2K[48–336] and
eEF2K[490–725] and 1 mM CaCl2 and 100μM CaM respectively. Binding of ATP-γSt o
Ca2+/CaMcouldbeexcludedbecauseoftheabsenceofSTDsignalsinanATP-γSCa 2+/CaM
solution (results not shown). The inset shows the structure of ATP-γS. (B) Dependence of
activity and ATP-cross-linking on Ca2+/CaM. To test ATP binding, recombinant GST–eEF2K
was incubated with [α-32P]ATP in the absence or presence of Ca2+ ions or CaM, as indicated.
Samples were subjected to UV irradiation as described in the Experimental section. In parallel,
other samples were incubated with [γ-32P]ATP and eEF2 to examine autophosphorylation of
eEF2K and activity against eEF2. Equal levels of eEF2K protein were conﬁrmed by staining the
gel with Coomassie Brilliant Blue (bottom panel). The other three panels show autoradiographs
of SDS/PAGE.
in the present study are an intrinsic property of eEF2K, not
merely onesconferred by the GST tag. Wewere unableto remove
the GST tag from the eEF2K[1–402] fragment without losing
solubility, but did succeed in doing so for the C-terminal region
without adverse effect. As shown in Figure 6(E), the untagged
eEF2K[478–725] fragment was also able to restore activity
to eEF2K[1–402], demonstrating that the effect is independent
of its GST tag and is an intrinsic property of these regions of the
eEF2K polypeptide.
These results are consistent with the idea that the C-terminal
domain of eEF2K may recruit not only eEF2, but also the MH-1
peptide for phosphorylation by the catalytic domain; the present
study shows that this works when the fragments are supplied in
trans, also implying that the C- and N-terminal fragments may
interact with one another even when not covalently linked as part
of the same polypeptide chain and this was tested in subsequent
experiments.
The discovery that addition of the eEF2K[478–725] fragment
allowed catalytic domain fragments to phosphorylate the MH-1
peptide allowed us to test the dependence of such activity
on Ca
2+/CaM. The activity of the eEF2K[64–356] fragment
against the MH-1 peptide (measured in the presence of the
C-terminal eEF2K[478–725] fragment) was strongly dependent
on Ca
2+/CaM (Figure 4C), in agreement with data for the
phosphorylation of eEF2 by the eEF2K[1–402] fragment in
the presence of eEF2K[478–725] (Figure 6A).
Regions ﬂanking the catalytic domain modify its activity
The discovery that the addition of the eEF2K[478–725]
fragment restored the ability of the catalytic domain fragments
to phosphorylate the MH-1 peptide allowed us to assess
whether regions adjacent to the catalytic domain affect its
activity in phosphorylating substrates in trans, rather than
autophosphorylation (analysed in Figure 4A). Removal of
residues 1–75 very strongly enhancedactivity compared with that
of the eEF2K[1–402] fragment (by >20-fold; compare 1–402 in
Figure 6B with 76–402 in Figure 6D), whereas truncation of the
latter fragment by removing residues 357–402 to create the 76–
356 fragment decreased it by approximately 2.5 fold compared
with the 76–402 polypeptide (Figure 6C). These results show
that the N-terminal domain exerts an inhibitory function, whereas
features of the 357–402 region may promote activity, both in
autophosphorylation (Figure 4A) and against the MH-1 peptide
(Figure 6B). The latter observation indicates that the reduced
activity of the fragments lacking residues 357–402 is not simply
due to removal of acceptor sites for autophosphorylation. The
autophosphorylation of the eEF2K[64–356] and eEF2K[64–402]
fragments was almost completely dependent upon Ca
2+/CaM
(Figure 4B).
The catalytic and SEL1 domains interact stably and directly
To examine whether the C- and N-terminal domains do indeed
interact stably, we ﬁrst used an ELISA-based approach coating
the wells of the plate with either GST–eEF2K[478–725] or (as
a negative control) GST. GST–eEF2K[1–402]–His6 was then
added, and after extensive washing, detection was with Ni-NTA–
HRP conjugate. As shown in Figure 7(A), a strong GST–
eEF2K[1–402]–His6-dependent signal was observed in wells
coated with GST–eEF2K[478–725], but not when GST itself was
used. This conﬁrms that the interaction between these domains
is not mediated by GST and implies that the N- and C-terminal
domains of eEF2K do indeed interact with each other in a rather
stable manner.
We considered it important to conﬁrm this interaction using
additional approaches using fragments expressed without GST
tags. The eEF2K[48–336] fragment was expressed with His6
and Z tags, and the C-terminal eEF2K[490–725] fragment with
only a His6 tag. A mixture of the two eEF2K fragments, together
with CaM, was applied to SP Sepharose, a cation exchange
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Figure 6 Activities of catalytic fragments against eEF2 or the MH-1 peptide depends on the presence of the eEF2K[478–725] fragment
(A) GST–eEF2K[1–402] was incubated with eEF2 in the presence of [γ-32P]ATP in the absence or presence of Ca2+ ions, CaM and/or the eEF2K[478–725] fragment as indicated. The Figure
shows an autoradiograph of the resulting gels. (B–D) GST–eEF2K[1–402], [76–356] or [76–402] was incubated with the MH-1 peptide in the presence of [γ-32P]ATP in the presence of Ca2+ ions
and CaM with or without the eEF2K[478–725] fragment. (E) The indicated proteins were incubated with eEF2 and non-radioactive ATP. Reaction products were analysed by SDS/PAGE and Western
blotting with the anti-eEF2 (P)Thr56 antibody (pT56) or anti-eEF2 as a loading control.
resin. The Z tag has a strong positive charge and thus the Z
tag/eEF2K[48–336]fragmentbindstoSPSepharoseandiseluted
withhighlevelsofsalt(Figure7B,lane5),whereastheC-terminal
eEF2K[490–725] fragment was not itself retained on this resin
(Figure 7C, lane 7). Excess eEF2K[490–725], which tends to
be expressed at higher levels than the other fragment, ﬂowed
through the column when the two proteins were applied together
(Figure 7B, lanes 4 and 6). The same behaviour was observed in
the presence or absence of Ca
2+ ions (Figure 7B, lanes 4–7) or
in the absence of CaM (Figure 7C). These data indicate that the
fragmentscontainingthecatalyticandSEL1domainscaninteract
directly, and that this interaction is not dependent on Ca
2+/CaM.
As expected, CaM was also retained on the resin, but only in the
presence of Ca
2+ (Figure 7B, compare lanes 5 and 7).
To test the interactions between the N- and C-terminal
regions of eEF2K, we studied their behaviour by analytical gel-
permeation chromatography. The puriﬁed eEF2K[48–336] and
eEF2K[490–725] fragments were preincubated with or without
Ca
2+ ions and CaM, and then applied to the column. Under
all conditions they eluted as a single peak (Figure 7D), and
analysis of the fractions across the peak by SDS/PAGE revealed
the presence of similar amounts of the two fragments in all
fractions. Comparison with calibration standards revealed that
the peak seen in the absence of Ca
2+ and CaM corresponded with
a molecular mass of 66 kDa, which is in good agreement with the
expected size (60.4 kDa) of a heterodimer of the eEF2K[48–336]
and eEF2K[490–725] fragments. This ﬁnding provides further
evidence that the two fragments associate stably and reveals that
they do so in the absence or presence of Ca
2+/CaM. The peak
was, as expected, shifted slightly to the left (higher mass) in the
presence of CaM.
The extreme C-terminus of eEF2K is critical for its ability to
phosphorylate eEF2
Residues within this extreme C-terminal region are highly
conservedacrossalleEF2Ksequencesfromnematodesandechin-
oderms to mammals (Figure 8A). It has previously been reported
that removal of the extreme C-terminus of eEF2K abrogates
its ability to phosphorylate eEF2, but not a peptide substrate
(MH-1; [23]) and that loss of even only the last 19 residues
abolishes the ability to phosphorylate eEF2 [24]. The fact that
truncation of the C-terminus did not prevent autophosphorylation
or phosphorylation of MH-1 indicates that this region is not
actuallyrequiredforkinasefunction,butratherforactivityagainst
eEF2, and perhaps for interaction with this substrate.
To test the importance of these residues, we assayed the
activity of full length eEF2K and a truncated protein lacking
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Figure 7 The catalytic and SEL1 domains of eEF2K interact directly
(A) An ELISA-based approach, described in the Experimental section, was used to study interactions between GST–eEF2K[1–402] and GST–eEF2K[478–725] (or, as a negative control, GST).
(BandC)ASPSepharoseresin-bindingassaywasperformedintheabsenceorpresenceofCa2+ ionsandCaMtostudytheinteractionsbetweenHis6–Zb–eEF2K[48–336]andHis6–eEF2K[490–725].
CaM and His6–eEF2K[490–725] were loaded separately as controls and showed no binding. (D) Gel ﬁltration was used to analyse the elution proﬁle of eEF2K[48–336] and eEF2K[490–725] in
theabsenceorpresenceofCa2+ andCaMasindicated.CaMwasloadedseparatelytoindicateitselutionproﬁleonitsown.TheinsetshowsaCoomassieBrilliantBlue-stainedSDS/PAGEgelofthe
fractionscorrespondingtothemainproteinpeak(elutionvolumes8.3–9.8ml;lowerpanel)runintheabsenceofCa2+ andCaM.ThisconﬁrmedequallevelsofeEF2K[48–336]andeEF2K[490–725]
across the peak [their migration positions are indicated, as are those of the indicated molecular weight markers (in kDa)]. Abs, absorbance; FT, ﬂow-through material.
theﬁnal15residues( 15-eEF2K)againsteEF2(Figure8B).The
full-length eEF2K readily phosphorylated eEF2, showing high
activity against the highest concentrations of eEF2 tested in the
assay;incontrast,thetruncatedproteinshowednoactivityagainst
eEF2 at any concentration tested. Thus the ﬁnal 15 residues are
essential for the ability of eEF2K to phosphorylate eEF2, and the
fact that no activity is seen even at high substrate concentrations
shows that this effect is not simply due to a change in the Km
value (afﬁnity) for eEF2. When tested against the MH-1 peptide,
the 15truncationshowedsubstantialactivity(about50–60%of
that of the full-length protein) at all of the peptide concentrations
tested. These results indicate: (i) that the C-terminal region also
aids phosphorylation of this substrate; but (ii) that, in distinction
to eEF2, it is not essential for phosphorylation of the MH-1
peptide. The data also provide further evidence that the loss
of activity of the  15 truncation against eEF2 is unlikely to
be due to an increase in the Km value for this substrate, since,
if that were the case, detectable activity should be observed at
increasing substrate concentrations. However, we cannot rule out
the possibility that the deletion of the last 15 residues causes such
a drastic decrease in the afﬁnity for eEF2 that even a 10-fold
increase in eEF2 concentration is insufﬁcient to allow detectable
phosphorylation.
These data prompt a key question: which feature(s) within
the far C-terminal region are required for phosphorylation of
eEF2 by eEF2K? To address this, we ﬁrst created a series
of truncation mutants in which either the ﬁnal four, six or eight
residues, or 15 or 19 amino acids were removed (Figure 8C). The
ﬁnalfourresiduesareabsentfromthenematodeeEF2Ksequences
(Figure8A),whereastheprecedingfourarenotconservedinthese
sequences, but generally are in other eEF2K proteins. Loss of up
to eight residues did not affect the activity of eEF2K against
eEF2, but removal of the next seven ( 15) completely eliminated
detectable activity against this substrate. These residues are
generally conserved among eEF2Ks from diverse species, some
universally so (Figure 8A).
Having demonstrated the key importance of residues 711–718
for phosphorylation of eEF2, we then mutated several completely
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Figure 8 The C-terminal tip of eEF2K is required for phosphorylation of eEF2
(A) Amino acid sequence alignment of the extreme C-termini of eEF2K from the indicated species. Sequence differences relative to human are noted in the single letter code; ‘-’ indicates identity.
Highly conserved residues tested here are boxed. (B) The activities of wild-type (WT) GST–eEF2K and the  15 truncated protein (GST–eEF2K[1–710]) against various concentrations of eEF2 or
the MH-1 peptide. The relative amounts of eEF2 are indicated above each lane (10 corresponds to a ﬁnal eEF2 concentration of 0.22mg/ml). Assays against the MH-1 peptide were also performed
in the absence of GST–eEF2K (-kinase). The ﬁnal concentrations are given in the Figure. Assays were performed as described in the Experimental section. (C–E) The activities of the indicated
truncation and/or point mutated versions of eEF2K were determined against eEF2 (C and D) or the MH-1 peptide (E). The wild-type (WT) eEF2K and truncation mutants tested in (C) were expressed
in HEK-293 cells. Other data used eEF2K proteins expressed in E. coli.( C and D) show autoradiographs of stained SDS/PAGE gels, with the positions of GST–eEF2K (eEF2K) and eEF2 being noted.
The results in (E) are means+ −S.D. (F) The indicated combinations of recombinant GST–eEF2K-based proteins were incubated with eEF2 and non-radioactive ATP. Reaction products were analysed
by SDS/PAGE and Western blotting with the anti-eEF2 (P)Thr56 (pT56) antibody or anti-eEF2 antibody as a loading control.
conserved residues within this region (Figure 8D). Mutation of
either of the universally conserved tyrosine residues to alanine
(the Y712A and Y713A mutants) led to a partial loss of activity
against eEF2 (Figure 8C), but only had a modest (Y712A) or no
(Y713A)effectontheabilitytophosphorylateMH-1(Figure8E).
The double mutant showed a complete loss of activity against
eEF2 (Figure 8C), but retained considerable activity against
MH-1 (Figure 8D). Ala
716 is universally conserved and lies in a
region predicted to adopt an α-helical conformation; to disrupt
this, we mutated Ala
716 to a proline residue. This drastically
decreasedactivityagainsteEF2(Figure8D),buthadlittleeffecton
the activity against the MH-1 peptide (Figure 8E). Glu
717 is also
universally conserved, but mutating it to alanine, to eliminate
the negative charge, actually enhanced activity against eEF2 and,
strikingly, also increased phosphorylation of the MH-1 peptide
(Figures 8C and 8D).
Taken together, these data extend earlier ﬁndings by revealing
that the conserved pair of tyrosine residues near the C-terminus
of eEF2K is critical for phosphorylation of eEF2, and that they
also play a role in the phosphorylation of the non-physiological
MH-1 peptide substrate (albeit to a much lesser extent). As
discussed above, the C-terminal part may recruit substrates for
c   The Authors Journal compilation c   2012 Biochemical Society © 2011 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.116 C. R. Pigott and others
Figure 9 Summary scheme
This diagram depicts a model for the structural organization of eEF2K which is described in the Discussion section. P indicates the presence of several phosphorylation sites in the linker region.
phosphorylation by the N-terminal domain. One might therefore
expectthatatruncated(e.g. 15)versionoftheC-terminalregion
wouldfailtorestoreactivitytothe1–402fragment;unfortunately,
despite strenuous efforts, we were unable to express the 478–710
fragment or a version of 478–725 in which the two key tyrosine
residues were mutated.
We therefore adopted an alternative approach where we ﬁrst
studied whether the intact C-terminal domain fragment of eEF2K
could restore activity to eEF2K[ 15]. As shown in Figure 8(F), it
was indeed able to do so, yielding a level of activity only slightly
below that seen for eEF2K itself or for the 1–402 plus 478–725
combination (Figure 8F). This implies that the 478–725 region
can recruit eEF2 for phosphorylation by the catalytic domain of
the eEF2K[ 15] protein. This effect was independent of the GST
tag on the C-terminal fragment (Figure 6E).
DISCUSSION
Two previous studies provided initial insights into the functions
of the domains of eEF2K [23,24]. Pavur et al. [23] conducted a
comprehensive deletion analysis of eEF2K, removing sections of
roughly 50 residues from the protein. Although this approach
carries a higher risk of causing misfolding of the internally
deleted polypeptide, the authors’ conclusions largely concur
with those of the present study, in that we ﬁnd that the
regions between residues 1–75 and 357–477 are not required
for function, whereas the section 76–356 shows activity, at least
in autophosphorylation, and the C-terminal region 478–725 is
required for phosphorylation of eEF2. Pavur et al. [23] found
that, although some variants of eEF2K with deletions within the
C-terminal region could still phosphorylate the MH-1 peptide, a
numberofotherscouldnot,andmostdidsoatagreatlydecreased
rate. These ﬁndings are broadly consistent with the results of the
present study. Diggle et al. [24] found that removal of the ﬁnal
19 amino acids abolished the ability of eEF2K to phosphorylate
eEF2, in line with the present ﬁndings, but also reported that
removing the last 133 residues eliminated autophosphorylation.
This is at odds with the results of the present study, which
show that even fragments as short as 76–356 undergo robust
autophosphorylation.
The CaM target database (http://calcium.uhnres.utoronto.ca/
ctdb/ctdb/home.html) indicates a CaM-binding site at residues
514–526ineEF2K(sequenceLEKKIGKSILGKVHL).However,
the results of the present study show that the entire C-terminal
region is dispensable for the control of eEF2K activity by
Ca
2+/CaM. Our data also show that the eEF2K[478–725]
fragment cannot bind CaM (C.R. Pigott, unpublished work) or
CaM–Sepharose, whereas full-length eEF2K can. These data are
consistent with previous work indicating that the CaM-binding
site lies immediately N-terminal to the catalytic domain, and
includes Trp
85 (equivalent to Trp
84 in rat eEF2K), which was
shown to be essential for binding to CaM [24].
The ﬁndings of the present study extend previous work in
a number of other ways. First, they imply that the N-terminal
region (e.g. residues 1–75) exerts an inhibitory effect on eEF2K
activity. Removal of this region enhances both the intrinsic
autophosphorylation of the resulting fragment and the activity (in
combination with the 478–725 region) against the MH-1 peptide.
Secondly, the results of the present study show that several
residues which appear to be universally conserved among
α-kinases are critical for activity. These data are in good
agreement with the effects of mutating the corresponding
conservedresiduesinTRPM7andwithdeductionsmadefromthe
crystal structures of the catalytic domains of other α-kinases, i.e.
ChaK1/TRPM7 and MHCKA [12,13]. This extends to residues
that are implicated in binding a metal ion; mutating these
residuesineEF2Kessentiallyabolisheskinasefunction.Wetested
whether incubation of eEF2K with metal ion-chelators such as
N,N,N
 ,N
 -tetrakis (2-pyridylmethyl)ethylenediamine might be
able to strip out the bound metal; however, this had no effect
on kinase activity (C.R. Pigott, unpublished work). It is possible
that, within the folded structure of eEF2K, the ion is inaccessible
to chelating agents.
Thirdly, our data identify speciﬁc residues in the extreme C-
terminus which are required for phosphorylation of eEF2. Our
data agree with those of Diggle et al. [24] who showed that
removing the last 19, but not the ﬁnal eight, residues from the
C-terminus of rat eEF2K abolished its ability to phosphorylate
eEF2 in vitro. This implies that the intervening residues, several
of which are absolutely conserved among eEF2K sequences
from species as diverse as nematodes and mammals, play a key
role in substrate phosphorylation. Focusing on those residues,
we show that the adjacent tyrosines (Tyr
712/Tyr
713 in human
eEF2K)arecriticalfortheabilitytophosphorylateeEF2,although
the eEF2K[Y712A/Y713A] mutant could still quite efﬁciently
phosphorylate the MH-1 peptide. Ala
716 is also crucial for this,
since mutating it to a proline residue abolishes activity against
eEF2.Interestingly,althoughGlu
717 isalsocompletelyconserved,
converting it into alanine actually enhanced activity, both against
eEF2 and the MH-1 peptide.
Importantly, the requirements for activity against eEF2
and the MH-1 peptide clearly differ quite markedly. Although
the eEF2K[478–725] region is essential for activity against
both, the removal of the C-terminal region had little effect
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on the ability to phosphorylate the MH-1 peptide, while
abolishing phosphorylation of eEF2 even at the highest substrate
concentrations tested. Thus the region containing the SEL1
domains and the extreme C-terminus is essential for the
phosphorylation of either substrate in trans, whereas the C-
terminal tail is only required for phosphorylation of the
physiological substrate eEF2. Mutating universally conserved
residues within this region strongly decreased activity against
eEF2 (e.g. the YY712/713AA and A716P mutants), but only
modestlyaffectedactivityagainsttheMH-1peptide.Thissuggests
that these residues might interact with eEF2 itself. However,
despite strenuous efforts using several approaches, we were
unabletodemonstrateastableinteractionusingwild-typeeEF2K,
so were unable to test the effect of these mutations.
Fourthly, it is striking that the N-terminal region containing
the kinase domain and the C-terminal section of eEF2K can
efﬁciently cooperate in trans to phosphorylate both eEF2 and
the MH-1 peptide, i.e. they do not need to be part of the same
polypeptide to do so. This is consistent with the ﬁnding that
these two regions associate with one another (when expressed
separately). This prompts the model shown in Figure 9 where
the C-terminal region, including the SEL1 domains and the tip,
recruit eEF2 to the catalytic domain for phosphorylation. Several
of the regulatory phosphorylation sites in eEF2K (e.g. Ser
359 [27],
Ser
366 [21],Ser
377 [22]orSer
398 [17])arelocatedintheintervening
‘linker’ region. It is tempting to speculate that phosphorylation
of these sites may inﬂuence the association of the N- and C-
terminal domains and thus modulate substrate recruitment and
activity. Further work is required to study this. It is interesting
to note that in TRPM7, another α-kinase, a region outside the
catalytic domain (immediately N-terminal to it) is again required
forcatalyticactivity[10],althoughseveralaspectsofthestructural
organization and control of this enzyme differ substantially from
those of eEF2K.
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